Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Dermatol Surg ; 46(4): 501-507, 2020 04.
Article in English | MEDLINE | ID: mdl-31688234

ABSTRACT

BACKGROUND: Telemedicine is an emerging field with numerous applications within medicine. Previous review articles describe its use within plastic surgery and otolaryngology but none, to the authors' knowledge, within dermatologic surgery. OBJECTIVE: To provide a review of the applications of telemedicine within dermatologic surgery. MATERIALS AND METHODS: A PubMed search of articles published on teledermatology was conducted in July 2018. Articles were selected based on their relevance to dermatologic surgery and reviewed for their discussion of the applications of telemedicine in surgical and cosmetic dermatology. RESULTS: The initial search resulted in 156 articles. Eleven ultimately met inclusion criteria: 2 in referral and consultation, 5 in telepathology, 2 in intraoperative uses, and 2 in postprocedural care. CONCLUSION: For preoperative consultation, teledermatology enables the surgeon to plan ahead and increases access to care by reducing the number of clinic visits. Telepathology has the potential to allow intraoperative consultation with a dermatopathologist to achieve accurate tumor clearance without delay. Smartglasses represent a promising technology for greater care coordination and a teaching tool. Postprocedural monitoring via text messaging provides convenient access to expert advice and early detection of postoperative complications. With increasing technologic advancements, telemedicine holds great potential to augment the dermatologic surgeon's daily practice.


Subject(s)
Dermatology/methods , Intraoperative Care/methods , Preoperative Care/methods , Telemedicine/trends , Cosmetic Techniques/instrumentation , Cosmetic Techniques/trends , Dermatologic Surgical Procedures/instrumentation , Dermatologic Surgical Procedures/trends , Dermatology/instrumentation , Dermatology/trends , Humans , Intraoperative Care/instrumentation , Intraoperative Care/trends , Preoperative Care/instrumentation , Preoperative Care/trends , Referral and Consultation/trends , Smart Glasses , Telemedicine/instrumentation
2.
JAMA Netw Open ; 1(6): e183062, 2018 10 05.
Article in English | MEDLINE | ID: mdl-30646223

ABSTRACT

Importance: Innovative, online models of specialty-care delivery are critical to improving patient access and outcomes. Objective: To determine whether an online, collaborative connected-health model results in equivalent clinical improvements in psoriasis compared with in-person care. Design, Setting, and Participants: The Patient-Centered Outcomes Research Institute Psoriasis Teledermatology Trial is a 12-month, pragmatic, randomized clinical equivalency trial to evaluate the effect of an online model for psoriasis compared with in-person care. Participant recruitment and study visits took place at multicenter ambulatory clinics from February 2, 2015, to August 18, 2017. Participants were adults with psoriasis in Northern California, Southern California, and Colorado. The eligibility criteria were an age of 18 years or older, having physician-diagnosed psoriasis, access to the internet and a digital camera or mobile phone with a camera, and having a primary care physician. Analyses were on an intention-to-treat basis. Interventions: Participants were randomized 1:1 to receive online or in-person care (148 randomized to online care and 148 randomized to in-person care). The online model enabled patients and primary care physicians to access dermatologists online asynchronously. The dermatologists provided assessments, recommendations, education, and prescriptions online. The in-person group sought care in person. The frequency of online or in-person visits was determined by medical necessity. All participants were exposed to their respective interventions for 12 months. Main Outcomes and Measures: The prespecified primary outcome was the difference in improvement in the self-administered Psoriasis Area and Severity Index (PASI) score between the online and in-person groups. Prespecified secondary outcomes included body surface area (BSA) affected by psoriasis and the patient global assessment score. Results: Of the 296 randomized participants, 147 were women, 149 were men, 187 were white, and the mean (SD) age was 49 (14) years. The adjusted difference between the online and in-person groups in the mean change in the self-administered PASI score during the 12-month study period was -0.27 (95% CI, -0.85 to 0.31). The difference in the mean change in BSA affected by psoriasis between the 2 groups was -0.05% (95% CI, -1.58% to 1.48%). Between-group differences in the PASI score and BSA were within prespecified equivalence margins, which demonstrated equivalence between the 2 interventions. The difference in the mean change in the patient global assessment score between the 2 groups was -0.11 (95% CI, -0.32 to 0.10), which exceeded the equivalence margin, with the online group displaying greater improvement. Conclusions and Relevance: The online, collaborative connected-health model was as effective as in-person management in improving clinical outcomes among patients with psoriasis. Innovative telehealth delivery models that emphasize collaboration, quality, and efficiency can be transformative to improving patient-centered outcomes in chronic diseases. Trial Registration: ClinicalTrials.gov Identifier: NCT02358135.


Subject(s)
Ambulatory Care/methods , Psoriasis/therapy , Telemedicine/methods , Adult , Female , Humans , Male , Outcome Assessment, Health Care , Psoriasis/epidemiology , Psoriasis/physiopathology , Severity of Illness Index , Treatment Outcome
3.
Stem Cells Dev ; 21(12): 2273-87, 2012 Aug 10.
Article in English | MEDLINE | ID: mdl-22236333

ABSTRACT

Embryonic definitive endoderm (DE) generates the epithelial compartment of vital organs such as liver, pancreas, and intestine. However, purification of DE in mammals has not been achieved, limiting the molecular "definition" of endoderm, and hindering our understanding of DE development and attempts to produce endoderm from sources such as embryonic stem (ES) cells. Here, we describe purification of mouse DE using fluorescence-activated cell sorting (FACS) and mice harboring a transgene encoding enhanced green fluorescent protein (eGFP) inserted into the Sox17 locus, which is expressed in the embryonic endoderm. Comparison of patterns of signaling pathway activation in native mouse DE and endoderm-like cells generated from ES cells produced novel culture modifications that generated Sox17-eGFP⁺ progeny whose gene expression resembled DE more closely than achieved with standard methods. These studies also produced new FACS methods for purifying DE from nontransgenic mice and mouse ES cell cultures. Parallel studies of a new human SOX17-eGFP ES cell line allowed analysis of endoderm differentiation in vitro, leading to culture modifications that enhanced expression of an endoderm-like signature. This work should accelerate our understanding of mechanisms regulating DE development in mice and humans, and guide further use of ES cells for tissue replacement.


Subject(s)
Cell Differentiation , Embryonic Stem Cells/metabolism , Endoderm/cytology , Animals , Antigens, Differentiation/genetics , Antigens, Differentiation/metabolism , Bone Morphogenetic Proteins/physiology , Cell Separation , Cells, Cultured , Cluster Analysis , Coculture Techniques , Embryo, Mammalian/cytology , Embryonic Stem Cells/cytology , Embryonic Stem Cells/physiology , Endoderm/metabolism , Fibroblast Growth Factors/physiology , Flow Cytometry , Green Fluorescent Proteins/biosynthesis , Green Fluorescent Proteins/genetics , Humans , In Situ Hybridization , Mice , Mice, Inbred C57BL , Mice, Transgenic , Oligonucleotide Array Sequence Analysis , SOXF Transcription Factors/genetics , SOXF Transcription Factors/metabolism , Signal Transduction , Transcriptome , Tretinoin/physiology
4.
Nat Genet ; 43(7): 621-9, 2011 Jun 05.
Article in English | MEDLINE | ID: mdl-21642992

ABSTRACT

Transcription of long noncoding RNAs (lncRNAs) within gene regulatory elements can modulate gene activity in response to external stimuli, but the scope and functions of such activity are not known. Here we use an ultrahigh-density array that tiles the promoters of 56 cell-cycle genes to interrogate 108 samples representing diverse perturbations. We identify 216 transcribed regions that encode putative lncRNAs, many with RT-PCR-validated periodic expression during the cell cycle, show altered expression in human cancers and are regulated in expression by specific oncogenic stimuli, stem cell differentiation or DNA damage. DNA damage induces five lncRNAs from the CDKN1A promoter, and one such lncRNA, named PANDA, is induced in a p53-dependent manner. PANDA interacts with the transcription factor NF-YA to limit expression of pro-apoptotic genes; PANDA depletion markedly sensitized human fibroblasts to apoptosis by doxorubicin. These findings suggest potentially widespread roles for promoter lncRNAs in cell-growth control.


Subject(s)
Genes, cdc/physiology , Neoplasms/genetics , Promoter Regions, Genetic/genetics , RNA, Untranslated/genetics , Transcription, Genetic/genetics , Apoptosis , Biomarkers/metabolism , Cell Cycle/physiology , Cell Differentiation , Chromatin Immunoprecipitation , DNA Damage , Gene Expression Profiling , Humans , Immunoprecipitation , Molecular Sequence Data , Neoplasms/pathology , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Transcriptional Activation
5.
Nat Med ; 16(12): 1450-5, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21102459

ABSTRACT

Refined cancer models are required if researchers are to assess the burgeoning number of potential targets for cancer therapeutics in a clinically relevant context that allows a fast turnaround. Here we use tumor-associated genetic pathways to transform primary human epithelial cells from the epidermis, oropharynx, esophagus and cervix into genetically defined tumors in a human three-dimensional (3D) tissue environment that incorporates cell-populated stroma and intact basement membrane. These engineered organotypic tissues recapitulated natural features of tumor progression, including epithelial invasion through basement membrane, a complex process that is necessary for biological malignancy in 90% of human cancers. Invasion was rapid and was potentiated by stromal cells. Oncogenic signals in 3D tissue, but not 2D culture, resembled gene expression profiles from spontaneous human cancers. We screened 3D organotypic neoplasia with well-characterized signaling pathway inhibitors to distill a clinically faithful cancer gene signature. Multitissue 3D human tissue cancer models may provide an efficient and relevant complement to current approaches to characterizing cancer progression.


Subject(s)
Cell Transformation, Neoplastic/genetics , Epithelial Cells/cytology , Models, Biological , Neoplasm Invasiveness/physiopathology , Neoplasms/genetics , Tissue Engineering/methods , Basement Membrane/cytology , Butadienes , Chromones , Gene Expression Profiling , Humans , Morpholines , Nitriles , Stromal Cells/cytology
6.
Nature ; 464(7291): 1071-6, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20393566

ABSTRACT

Large intervening non-coding RNAs (lincRNAs) are pervasively transcribed in the genome yet their potential involvement in human disease is not well understood. Recent studies of dosage compensation, imprinting, and homeotic gene expression suggest that individual lincRNAs can function as the interface between DNA and specific chromatin remodelling activities. Here we show that lincRNAs in the HOX loci become systematically dysregulated during breast cancer progression. The lincRNA termed HOTAIR is increased in expression in primary breast tumours and metastases, and HOTAIR expression level in primary tumours is a powerful predictor of eventual metastasis and death. Enforced expression of HOTAIR in epithelial cancer cells induced genome-wide re-targeting of Polycomb repressive complex 2 (PRC2) to an occupancy pattern more resembling embryonic fibroblasts, leading to altered histone H3 lysine 27 methylation, gene expression, and increased cancer invasiveness and metastasis in a manner dependent on PRC2. Conversely, loss of HOTAIR can inhibit cancer invasiveness, particularly in cells that possess excessive PRC2 activity. These findings indicate that lincRNAs have active roles in modulating the cancer epigenome and may be important targets for cancer diagnosis and therapy.


Subject(s)
Chromatin Assembly and Disassembly/genetics , Chromatin/genetics , Neoplasm Metastasis/genetics , RNA, Untranslated/genetics , Animals , Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Proliferation , Disease Progression , Epigenesis, Genetic , Female , Gene Expression Regulation, Neoplastic , Genes, Homeobox/genetics , Genome, Human/genetics , Histones/metabolism , Humans , Methylation , Mice , Mice, Nude , Mice, SCID , Middle Aged , Neoplasm Invasiveness , Neoplasm Transplantation , Polycomb-Group Proteins , Prognosis , RNA Interference , RNA, Untranslated/biosynthesis , Repressor Proteins/analysis , Repressor Proteins/metabolism , Survival Rate
7.
Cell Cycle ; 7(23): 3622-4, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19029796

ABSTRACT

The ability of cancers to grow indefinitely has fueled the idea that cancer and stem cells may have common underlying mechanisms. Detailed gene expression maps have now shown the diversity and distinctiveness in gene expression programs associated with stemness in embryonic and adult stem cells. These maps have further revealed a shared transcriptional program in embryonic stem cells (ESC) and cancer stem cells. Surprisingly, forced activation of an ESC-like gene expression program in adult epithelial cells can reprogram them into human cancer stem cells and achieve pathologic self-renewal. The ability to create induced cancer stem cells (iCSC) may provide opportunities to better define the biology of cancer stem cells in order to trace or eliminate them in human patients.


Subject(s)
Neoplasms/pathology , Neoplastic Stem Cells/pathology , Animals , Embryonic Stem Cells/metabolism , Embryonic Stem Cells/pathology , Gene Expression Regulation , Humans , Neoplasms/genetics , Neoplastic Stem Cells/metabolism
8.
Science ; 321(5890): 843-7, 2008 Aug 08.
Article in English | MEDLINE | ID: mdl-18687966

ABSTRACT

The prevention of autoimmunity requires the elimination of self-reactive T cells during their development and maturation. The expression of diverse self-antigens by stromal cells in the thymus is essential to this process and depends, in part, on the activity of the autoimmune regulator (Aire) gene. Here we report the identification of extrathymic Aire-expressing cells (eTACs) resident within the secondary lymphoid organs. These stromally derived eTACs express a diverse array of distinct self-antigens and are capable of interacting with and deleting naïve autoreactive T cells. Using two-photon microscopy, we observed stable antigen-specific interactions between eTACs and autoreactive T cells. We propose that such a secondary network of self-antigen-expressing stromal cells may help reinforce immune tolerance by preventing the maturation of autoreactive T cells that escape thymic negative selection.


Subject(s)
Autoantigens/immunology , Lymph Nodes/immunology , Lymphoid Tissue/cytology , Lymphoid Tissue/metabolism , Self Tolerance , T-Lymphocytes/immunology , Transcription Factors/metabolism , Adoptive Transfer , Animals , Antigen Presentation , Autoantigens/genetics , Autoimmunity , Cell Proliferation , Epithelial Cells/immunology , Gene Expression Regulation , Glucose-6-Phosphatase/immunology , Lymph Nodes/cytology , Lymph Nodes/metabolism , Lymphoid Tissue/immunology , Mice , Mice, Transgenic , Proteins/immunology , Spleen/cytology , Spleen/immunology , Spleen/metabolism , Stromal Cells/immunology , Stromal Cells/metabolism , Thymus Gland/cytology , Thymus Gland/immunology , Transcription Factors/genetics , Transcription, Genetic , AIRE Protein
9.
Cell Stem Cell ; 2(4): 333-44, 2008 Apr 10.
Article in English | MEDLINE | ID: mdl-18397753

ABSTRACT

Self-renewal is a hallmark of stem cells and cancer, but existence of a shared stemness program remains controversial. Here, we construct a gene module map to systematically relate transcriptional programs in embryonic stem cells (ESCs), adult tissue stem cells, and human cancers. This map reveals two predominant gene modules that distinguish ESCs and adult tissue stem cells. The ESC-like transcriptional program is activated in diverse human epithelial cancers and strongly predicts metastasis and death. c-Myc, but not other oncogenes, is sufficient to reactivate the ESC-like program in normal and cancer cells. In primary human keratinocytes transformed by Ras and I kappa B alpha, c-Myc increases the fraction of tumor-initiating cells by 150-fold, enabling tumor formation and serial propagation with as few as 500 cells. c-Myc-enhanced tumor initiation is cell-autonomous and independent of genomic instability. Thus, activation of an ESC-like transcriptional program in differentiated adult cells may induce pathologic self-renewal characteristic of cancer stem cells.


Subject(s)
Adult Stem Cells/physiology , Biomarkers, Tumor/metabolism , Embryonic Stem Cells/physiology , Epithelium/pathology , Neoplasms, Experimental/pathology , Neoplastic Stem Cells/pathology , Transcription, Genetic , Adult Stem Cells/cytology , Animals , Biomarkers, Tumor/genetics , Cell Proliferation , Cell Transformation, Neoplastic , Cells, Cultured , Chromatin Immunoprecipitation , DNA-Binding Proteins/metabolism , Embryonic Stem Cells/cytology , Fibroblasts/cytology , Fibroblasts/metabolism , Fluorescent Antibody Technique , Gene Expression Profiling , Gene Expression Regulation , Genes, ras/physiology , Genomic Instability , Humans , Immunoenzyme Techniques , Keratinocytes/cytology , Keratinocytes/metabolism , Mice , Mice, SCID , Neoplasms, Experimental/genetics , Neoplasms, Experimental/metabolism , Oligonucleotide Array Sequence Analysis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Transcription Factors/metabolism
10.
Cancer Res ; 68(2): 369-78, 2008 Jan 15.
Article in English | MEDLINE | ID: mdl-18199530

ABSTRACT

A major goal of cancer research is to match specific therapies to molecular targets in cancer. Genome-scale expression profiling has identified new subtypes of cancer based on consistent patterns of variation in gene expression, leading to improved prognostic predictions. However, how these new genetic subtypes of cancers should be treated is unknown. Here, we show that a gene module map can guide the prospective identification of targeted therapies for genetic subtypes of cancer. By visualizing genome-scale gene expression in cancer as combinations of activated and deactivated functional modules, gene module maps can reveal specific functional pathways associated with each subtype that might be susceptible to targeted therapies. We show that in human breast cancers, activation of a poor-prognosis "wound signature" is strongly associated with induction of both a mitochondria gene module and a proteasome gene module. We found that 3-bromopyruvic acid, which inhibits glycolysis, selectively killed breast cells expressing the mitochondria and wound signatures. In addition, inhibition of proteasome activity by bortezomib, a drug approved for human use in multiple myeloma, abrogated wound signature expression and selectively killed breast cells expressing the wound signature. Thus, gene module maps may enable rapid translation of complex genomic signatures in human disease to targeted therapeutic strategies.


Subject(s)
Chromosome Mapping/methods , Gene Regulatory Networks/physiology , Gene Targeting , Genetic Therapy , Neoplasms/genetics , Neoplasms/therapy , Algorithms , Antineoplastic Agents/therapeutic use , Boronic Acids/therapeutic use , Bortezomib , Breast Neoplasms/diagnosis , Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Electronic Data Processing , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Genes, Mitochondrial , Humans , Neoplasm Invasiveness , Neoplasms/classification , Neoplasms/pathology , Oligonucleotide Array Sequence Analysis , Prognosis , Proteasome Endopeptidase Complex/genetics , Pyrazines/therapeutic use , Tumor Cells, Cultured , Wounds and Injuries/genetics
11.
Cancer Res ; 68(2): 506-15, 2008 Jan 15.
Article in English | MEDLINE | ID: mdl-18199546

ABSTRACT

CSN5 has been implicated as a candidate oncogene in human breast cancers by genetic linkage with activation of the poor-prognosis, wound response gene expression signature. CSN5 is a subunit of the eight-protein COP9 signalosome, a signaling complex with multiple biochemical activities; the mechanism of CSN5 action in cancer development remains poorly understood. Here, we show that CSN5 isopeptidase activity is essential for breast epithelial transformation and progression. Amplification of CSN5 is required for transformation of primary human breast epithelial cells by defined oncogenes. The transforming effects of CSN5 require CSN subunits for assembly of the full COP9 signalosome and the isopeptidase activity of CSN5, which potentiates the transcriptional activity of MYC. Transgenic inhibition of CSN5 isopeptidase activity blocks breast cancer progression evoked by MYC and RAS in vivo. These results highlight CSN5 isopeptidase activity in breast cancer progression, suggesting it as a therapeutic target in aggressive human breast cancers.


Subject(s)
Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Carbon-Nitrogen Lyases/metabolism , Intracellular Signaling Peptides and Proteins/physiology , Multiprotein Complexes/metabolism , Peptide Hydrolases/metabolism , Peptide Hydrolases/physiology , Animals , Breast Neoplasms/enzymology , Breast Neoplasms/genetics , COP9 Signalosome Complex , Carbon-Nitrogen Lyases/physiology , Cell Transformation, Neoplastic/genetics , Disease Progression , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Humans , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Male , Mammary Neoplasms, Experimental/enzymology , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/pathology , Mice , Mice, Nude , Models, Biological , Neoplasm Transplantation , Peptide Hydrolases/genetics , Retroviridae/genetics , Transduction, Genetic , Tumor Cells, Cultured
12.
Bioorg Med Chem ; 14(13): 4627-38, 2006 Jul 01.
Article in English | MEDLINE | ID: mdl-16510287

ABSTRACT

The 4,5-diarylated-1H-pyrrole-2-carboxylates 3-8 have each been prepared as hybrids of the potent anti-mitotic agent combretastatin A-4 (1) and the similarly active marine alkaloid lamellarin T (2). The key steps involved selective lithium-for-halogen exchange at C5 within the N-PMB protected 4,5-dibromopyrrole 22 and Negishi cross-coupling of the derived zincated species with the relevant aryl iodide. The ensuing 5-aryl-4-bromopyrrole then engaged in Suzuki-Miyaura cross-coupling with the appropriate arylboronic acid to give the 4,5-diarylated pyrroles 4, 6 and 8. TFA-promoted removal of the N-PMB group within these last compounds then gave the N-unsubstituted congeners 3, 5 and 7. Compounds 3-8 have all been evaluated for their anti-mitotic and cytotoxic properties and two of them, 3 and 5, display useful activities although they are less potent than combretastatin A-4.


Subject(s)
Antibiotics, Antineoplastic/chemistry , Antimitotic Agents/chemistry , Heterocyclic Compounds, 4 or More Rings/chemistry , Proline/analogs & derivatives , Stilbenes/chemistry , Tubulin/drug effects , Animals , Antibiotics, Antineoplastic/chemical synthesis , Antibiotics, Antineoplastic/pharmacology , Antimitotic Agents/chemical synthesis , Antimitotic Agents/pharmacology , Cattle , Proline/chemistry
13.
J Invest Dermatol ; 125(2): 175-82, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16098025

ABSTRACT

Global gene expression patterns can provide comprehensive molecular portraits of biologic diversity and complex disease states, but understanding the physiologic meaning and genetic basis of the myriad gene expression changes have been a challenge. Several new analytic strategies have now been developed to improve the interpretation of microarray data. Because genes work together in groups to carry out specific functions, defining the unit of analysis by coherent changes in biologically meaningful sets of genes, termed modules, improves our understanding of the biological processes underlying the gene expression changes. The gene module approach has been used in exploratory discovery of defective oxidative phosphorylation in diabetes mellitus and also has allowed definitive hypothesis testing on a genomic scale for the relationship between wound healing and cancer and for the oncogenic mechanism of cyclin D. To understand the genetic basis of global gene expression patterns, computational modeling of regulatory networks can highlight key regulators of the gene expression changes, and many of these predictions can now be experimentally validated using global chromatin-immunoprecipitation analysis.


Subject(s)
Dermatology , Oligonucleotide Array Sequence Analysis , Skin Diseases/genetics , Skin Physiological Phenomena/genetics , Animals , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...